Forteo 560 MCG/2.24 ML pen INJ 2.24ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7UQ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,763
Award facts
- Contract value 100% obligated
- $13,762.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,762.96 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 mL pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026.
Forteo is a prescription medication used primarily to treat osteoporosis in patients at high risk for fractures. The delivery order represents a routine pharmaceutical procurement by the Defense Logistics Agency to support military healthcare systems and other federal medical supply needs. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability as a critical vendor for the DLA Medical Supply Chain, supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's competitively awarded contracts with the Defense Logistics Agency reflect its significant role in providing essential medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F7UQ4?
SPE2DR26F7UQ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F7UQ4 worth?
The government has obligated $13,763 on SPE2DR26F7UQ4.
Is contract SPE2DR26F7UQ4 an order under another contract?
Yes. SPE2DR26F7UQ4 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UQ4 competed?
The extent of competition for SPE2DR26F7UQ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award